Pw. Caton et al., INVOLVEMENT OF NITRIC-OXIDE IN NITROUS-OXIDE ANXIOLYSIS IN THE ELEVATED PLUS-MAZE, Pharmacology, biochemistry and behavior, 48(3), 1994, pp. 689-692
We recently reported that inhibition of nitric oxide (NO) production b
y the NO synthase NOS) inhibitor L-N-G-nitro arginine (L-NOARG) antago
nized the behavioral effects of a benzodiazepine (BZ) in a mouse parad
igm for screening anxiolytic drug activity. Because other research has
found that the anesthetic gas nitrous oxide (N2O) also produces BZ-li
ke behavioral effects, the present research was conducted to ascertain
whether NO might also be involved in N2O anxiolysis. Male Swiss-Webst
er mice were tested in an elevated plus-maze inside an inflatable glov
ebag. Exposure to N2O significantly increased exploratory activity on
the open arms of the plus-maze, as measured by the number of entries i
nto the open arms and the time spent on the open arms. Pretreatment wi
th L-NOARG significantly reduced the N2O-induced elevation in open arm
activity. This antagonism of the N2O effect was reversed by ICV treat
ment of L-NOARG-pretreated mice with L-arginine but not D-arginine. Th
ese findings indicate that NO possibly mediates behavioral effects of
N2O in an animal model for anxiety.